Skip to main content

Table 3 Top 20 potential SUMO-1 targeting TFs after KSHV reactivation

From: The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi’s sarcoma associated herpesvirus reactivation

Rank

Name

Transfac

TFBS # (in TSS±500 bp)

Peak # of TFBS (in TSS±500 bp)

% of TFBS Peak (in TSS±500 bp)

Gene #

0 h

12 h

0 h

12 h

0 h

12 h

1

ETS1

V$CETS1P54_01

1587

341

262

21.5%

16.5%

294

229

2

STAT4

V$STAT4_01

106

17

17

16.0%

16.0%

4

4

3

ELK1

V$ELK1_02

1667

333

254

20.0%

15.2%

279

215

4

GABPA/NRF-2

V$NRF2_01

1577

336

237

21.3%

15.0%

286

206

5

STAT1

V$STAT1_03

282

50

41

17.7%

14.5%

48

39

6

NFATC1/2/3/4

V$NFAT_Q6

487

48

70

9.9%

14.4%

22

23

7

STAT5A

V$STAT5A_02

982

118

129

12.0%

13.1%

95

104

8

MYC/MAX

V$MYCMAX_02

580

90

76

15.5%

13.1%

68

55

9

CREB1

V$CREB_01

666

103

87

15.5%

13.1%

97

83

10

CUTL1

V$CDPCR1_01

582

59

73

10.1%

12.5%

54

49

  1. bold: transcription factor with evidence of SUMO modification.